Related Experiment Video
Updated: Feb 15, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Viral safety of coagulation factor concentrates: memoirs from an insider
1Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Ca' Granda Maggiore Policlinico Hospital Foundation, Milan, Italy.
Abstract:
The purpose of this essay is to recall the actions taken globally to improve the viral safety of coagulation factor concentrates, mainly in the years 1985-1990, at a time of confusing and often contradictory information on bloodborne viral infections in multitransfused patients with hemophilia (PWHs). I shall first recall the problem of the transmission and control of the hepatitis viruses, and then that of HIV: not only for temporal reasons, but also because understanding the progress of knowledge on hepatitis and the poor success of the early measures taken to tackle this problem in PWHs is essential to understand how the problem of HIV transmission was ultimately dealt with successfully.
Insights
Global efforts in 1985-1990 improved viral safety for coagulation factor concentrates. Lessons from hepatitis control informed successful HIV transmission strategies in patients with hemophilia.
Area of Science:
- Hematology
- Virology
- Public Health
Background:
- Coagulation factor concentrates are crucial for patients with hemophilia (PWHs).
- The period 1985-1990 saw significant challenges with bloodborne viral infections, including hepatitis and HIV, in PWHs.
- Confusing information complicated the management of viral safety in hemophilia treatment.
Observation:
- Early measures to control hepatitis transmission in PWHs had limited success.
- Understanding hepatitis control failures provided critical insights.
- The progression of knowledge on viral transmission was essential for developing effective strategies.
Findings:
- Global actions were taken to enhance viral safety of coagulation factor concentrates.
- The approach to HIV transmission control was ultimately successful.
- Knowledge gained from hepatitis virus control informed HIV strategies.
Implications:
- Improved viral safety protocols for blood products are vital.
- Historical analysis of viral outbreaks informs current public health responses.
- Successful strategies for managing bloodborne viruses in immunocompromised populations can be developed through rigorous scientific understanding and adaptive measures.
Related Concept Videos
Coagulation
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Survey Safety
Viral Recombination
Solution Concentration and Dilution
Viral Structure

